Bodisen Biotech Completes Dual Listing Of Shares On London Stock Exchange AIM; Raised US$21.36 Million Strategic Financing With UK Institutional Investors
Published: Feb 06, 2006
NEW YORK--(BUSINESS WIRE)--Feb. 6, 2006--Bodisen Biotech, Inc., (AMEX:BBC, London AIM:BODI, website: www.bodisen.com), the first China based environmentally friendly bio fertilizer company listed on a US stock exchange, announced the successful completion of financing and dual listing of its US shares on the London Stock Exchange AIM market. Bodisen sold 1,643,836 (slightly over 9% of post offering outstanding shares) at GBP 7.30 (Approximately US$13) per share. No warrants or options were associated with this offering. Bodisen has a total of 17,764,836 shares outstanding after the transaction. Bodisen will primarily use the proceeds to expand manufacturing facilities and marketing to two new large farming regions of China which each has the similar manufacturing capacity and revue potentials as Bodisen's existing facilities.